Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · Real-Time Price · USD

0.4497

-0.0003 (-0.07%)

Jul 29, 2026, 10:25 AM EDT - Market open

Pasithea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.5	55.26	6.92	16.33	33.09	52.97
Cash & Short-Term Investments	50.5	55.26	6.92	16.33	33.09	52.97
Cash Growth	845.49%	698.24%	-57.61%	-50.64%	-37.53%	-
Other Receivables	-	-	-	0.04	-	-
Total Trade Receivables	-	-	-	0.04	-	-
Other Current Assets	2.23	1.2	0.45	0.32	0.99	0.33
Total Current Assets	52.73	56.46	7.37	16.69	34.08	53.3
Net Property, Plant & Equipment	-	-	0.12	0.22	0.63	0.02
Other Intangible Assets	3.62	3.78	7.31	7.94	8.57	-
Goodwill	-	-	1.26	1.26	1.26	-
Other Long-Term Assets	-	-	-	-	0.64	-
Total Assets	56.35	60.24	16.06	26.12	45.18	53.32

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.49	1.13	1.12	2.55	1.48	0.45
Current Portion of Leases	-	-	-	0.08	0.16	-
Other Current Liabilities	-	3.84	-	-	0.24	-
Total Current Liabilities	1.49	4.97	1.12	2.63	1.88	0.45
Long-Term Leases	-	-	-	-	0.34	-
Other Long-Term Liabilities	0.05	0.05	0.16	0.08	0.46	1.45
Total Long-Term Liabilities	0.05	0.05	0.16	0.08	0.8	1.45
Total Liabilities	1.54	5.02	1.28	2.72	2.68	1.9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0.02
Additional Paid-in Capital	127.64	125.21	64.37	58.72	61.86	53.63
Accumulated Other Comprehensive Income	0.05	0.02	-0.01	-0	-0	-0.01
Retained Earnings	-72.88	-70.01	-49.58	-35.32	-19.36	-2.21
Shareholders' Equity	54.81	55.22	14.78	23.4	42.5	51.42
Total Liabilities & Equity	56.35	60.24	16.06	26.12	45.18	53.32

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0	0	0.08	0.5	0
Net Cash (Debt)	50.5	55.26	6.92	16.25	32.58	52.97
Net Cash Growth	845.49%	698.24%	-57.40%	-50.13%	-38.48%	-
Net Cash Per Share	4.03	7.86	6.32	13.25	25.81	101.81
Book Value	54.81	55.22	14.78	23.4	42.5	51.42
Book Value Per Share	4.37	7.85	13.49	19.08	33.67	98.84
Tangible Book Value	51.19	51.44	6.21	14.19	32.66	51.42
Tangible Book Value Per Share	4.08	7.32	5.66	11.57	25.88	98.84

SEC Filings: 10-K · 10-Q